ANTX
AN2 TherapeuticsDNasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
Quote time unavailable
+
Peers tracked
11
U.S. public peers
Grade Position
In line
vs peer average
ANTX vs peer average
49/100
ANTX vs. peer average (D vs. D)
Grade spread
A 1 · B 1 · D 5 · F 4
Graded peers loaded
Coverage
11 graded
100% of tracked
Peer overview
MRKR is the first available peer comparator.
Clinical-stage micro-cap biotech with event-driven trading and funding sensitivity; useful for comparing how ANTX may respond to milestone slippage versus cash support.
✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
ANTX
AN2 Therapeutics
MRKR
Marker Therapeutics
Grade
D
D
Momentum
93
74
Value
41
41
Sentiment
32
-
Setup Bias
Net —
-
Market Cap
-
-
Posture
Defensive
Defensive
Grade position vs MRKR
ANTX / MRKR
Grade Position
In line
ANTX vs. peer average (D vs. D)
49/100
Momentum
93
ANTXValue
41
ANTXSentiment
32
-Rotation landscape
Peers ranked by the order returned from the peer source, with grades from the API.
Rank
Ticker
Company
Grade
Grade score
vs ANTX
MRKR is the first peer returned for this comparison set.

